WeVote
Log In

Bill

Bill

HF 981

Opioid prevention and education funding provided, and money appropriated.

2025-2026 Regular Session Introduced by Patty Acomb and 10 co-sponsors

HF 981 would allocate state funds to opioid prevention and education, supporting Health Dept., schools, and communities to reduce misuse and raise awareness in Minnesota.

Author added Bahner
#drugsandmedicine #healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · HF 981

Summary: House File 981 (HF 981) — Opioid prevention and education funding provided, and money appropriated

Overview

HF 981 is a Minnesota House bill introduced on March 31, 2025, with the stated aim of providing funding for opioid prevention and education and appropriating money for related programs. The bill has a primary sponsor listed as Sieck, with several authors added during the introduction and early session actions (Acomb, Pursell, Koegel, Bahner). The companion Senate bill is SF 1138.

Note on text discrepancy: The version content provided for HF 981 appears to describe a separate topic (real property owners’ rights against unauthorized occupants and trespass) rather than opioid prevention and education funding. The substance detailed in that text does not match the bill’s title or subject. The summary below focuses on the bill as described by its title and known legislative actions; no specific opioid-related provisions are included in the provided content.

Purpose and intent

  • To allocate state funds for opioid prevention and education initiatives.
  • To support programs and activities aimed at reducing opioid misuse, increasing awareness, prevention education, and related efforts within Minnesota.
  • To establish or guide the use of appropriated funds for state agencies, local jurisdictions, schools, and community organizations involved in prevention and education.

Key provisions (as far as the provided information allows)

  • The bill’s headline indicates money would be appropriated for opioid prevention and education. However, the specific provisions (e.g., exact appropriation amounts, eligible recipients, grant mechanisms, grant periods, allowable uses, reporting requirements, match requirements, and oversight) are not provided in the text excerpt.
  • The accompanying, non-matching text block supplied with HF 981 describes unrelated real-property trespass procedures and penalties, which does not appear to pertain to opioid funding. Readers should consult the official bill language for the precise provisions.

Note: Because the detailed statutory language is not included here, the above highlights are limited to the bill’s stated purpose in the title and the procedural history.

Who would be affected

  • State agencies responsible for public health and substance use prevention (e.g., Minnesota Department of Health, Department of Human Services).
  • Local governments, schools, and community organizations implementing opioid prevention and education programs.
  • recipients of state opioid prevention funding, including non-profit organizations and healthcare providers involved in prevention, education, and early intervention efforts.
  • The public health and safety landscape in Minnesota, through funded prevention initiatives and education campaigns.

Procedural and timeline aspects

  • Introduced: March 31, 2025.
  • Initial action: Referred to Judiciary (per the listed legislative actions; note: the health-focused origin suggests it may also move through Health Finance and Policy).
  • Earlier author activity included additions of Acomb, Pursell, Koegel; Bahner added as an author on February 27, 2025.
  • Senate companion: SF 1138.
  • Next steps typically include committee hearings (initially in Health Finance and Policy or a relevant committee, given the public health focus), potential amendments, and floor votes in both chambers.

Sponsors and related legislation

  • Primary sponsor: SIECK.
  • Additional authors throughout early 2025: Acomb, Pursell, Koegel, Bahner.
  • Companion bill: SF 1138.

Practical considerations

  • Fiscal impact: The bill would create or authorize appropriations; the exact amounts and funding structure are not provided here.
  • Accountability: For opioids programs, expect potential reporting requirements to evaluate program effectiveness, outcomes, and fund utilization.
  • Oversight: Likely involvement of health and human services agencies and legislative committees overseeing public health funding.

For a complete understanding, review the official HF 981 text, amended versions, and the Senate companion SF 1138 to confirm the exact allocation details, eligibility, match requirements (if any), and reporting and sunset provisions.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.